Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs

• Published in: Archives of pharmacal research Vol. 40; no. 12; pp. 1345 - 1355
• Main Authors: Noh, Keumhan, Kang, You Ra, Nepal, Mahesh Raj, Shakya, Rajina, Kang, Mi Jeong, Kang, Wonku, Lee, Sangkyu, Jeong, Hye Gwang, Jeong, Tae Cheon
• Format: Journal Article
• Language: English
• Published: Seoul Pharmaceutical Society of Korea 01.12.2017; 대한약학회
• Subjects: absorption; bioavailability; drugs; enzymatic reactions; intestinal microorganisms; intestinal mucosa; liver; Medicine; metabolites; pharmacodynamics; pharmacokinetics; Pharmacology/Toxicology; Pharmacy; Review; 약학; Gut microbiota; Drug metabolism; Pharmacodynamics; Pharmacokinetics; Toxicity
• ISSN: 0253-6269; 1976-3786; 1976-3786
• DOI: 10.1007/s12272-017-0986-y

The intestinal mucosa and liver have long been considered as the main sites of drug metabolism, and the contribution of gut microbiota to drug metabolism has been under-estimated. However, it is now generally accepted that the gut microbiota plays an important role in drug metabolism prior to drug absorption or during enterohepatic circulation via various microbial enzymatic reactions in the intestine. Moreover, some drugs are metabolized by gut microbiota to specific metabolite(s) that cannot be formed in the liver. More importantly, the metabolism of drugs by gut microbiota prior to absorption can alter the systemic bioavailability of certain drugs. Therefore, understanding drug metabolism by gut microbiota is critical for explaining changes in the pharmacokinetics of drugs, which may cause significant alterations in drug-induced pharmacodynamics and toxicities. In this review, we describe recent progress with regard to the role of metabolism by gut microbiota in some drug-induced alterations of either pharmacological or toxicological effects to emphasize the clinical importance of gut microbiota for safe and effective use of drugs.